Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
IntelliPharmaCeutics International (IPCIF)
OTHER OTC:IPCIF
Holding IPCIF?
Track your performance easily
IPCIF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.15
Previous Close$0.15
Volume5.00
Average Volume (3M)N/A
Market Cap
$2.39M
Enterprise Value$4.20M
Total Cash (Recent Filing)$400.10K
Total Debt (Recent Filing)$2.22M
Price to Earnings (P/E)―
Beta2.64
Next Earnings
Apr 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding33,092,665
10 Day Avg. Volume1
30 Day Avg. VolumeN/A
Standard Deviation0.75
R-Squared0.01
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.33
Price to Cash Flow (P/CF)2.00
P/FCF Ratio1.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.01
Enterprise Value/Gross Profit63.97
Enterprise Value/Ebitda-1.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IntelliPharmaCeutics International News
PremiumCompany Announcements
Intellipharmaceutics Hit by Market DowngradeOwnership Overview
―
Insiders
―
Mutual Funds
5.56% Other Institutional Investors
94.44% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
IPCIF FAQ
What was IntelliPharmaCeutics International’s price range in the past 12 months?
IntelliPharmaCeutics International lowest stock price was $0.02 and its highest was $0.15 in the past 12 months.
What is IntelliPharmaCeutics International’s market cap?
Currently, no data Available
When is IntelliPharmaCeutics International’s upcoming earnings report date?
IntelliPharmaCeutics International’s upcoming earnings report date is Apr 21, 2025 which is in 159 days.
How were IntelliPharmaCeutics International’s earnings last quarter?
Currently, no data Available
Is IntelliPharmaCeutics International overvalued?
According to Wall Street analysts IntelliPharmaCeutics International’s price is currently Overvalued.
Does IntelliPharmaCeutics International pay dividends?
IntelliPharmaCeutics International does not currently pay dividends.
What is IntelliPharmaCeutics International’s EPS estimate?
IntelliPharmaCeutics International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IntelliPharmaCeutics International have?
IntelliPharmaCeutics International has 35,002,666 shares outstanding.
What happened to IntelliPharmaCeutics International’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IntelliPharmaCeutics International?
Currently, no hedge funds are holding shares in IPCIF
---
IntelliPharmaCeutics International Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
IntelliPharmaCeutics International
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
---
---